: A refined commercial strategy identified high-priority opportunities in applied and research markets worth an estimated $13 to $14 billion .
"5414X" is the RNS (Regulatory News Service) identifier for the released by Oxford Nanopore Technologies plc .
: 58.2%, slightly down from 58.8% in H1 2024 due to one-off inventory charges and currency headwinds, despite an underlying improvement of 525 basis points. Segment Growth : Segment Growth : The full text and detailed
The full text and detailed report of this "paper" (regulatory announcement) include the following key sections and financial highlights:
: Introduced next-generation automated flow cell lines and strengthened quality assurance to ISO 13485 standards. : £12
Co-founder and CEO announced he will step down from his role and the board by the end of 2026.
: Completed a programme resulting in an approximately 5% reduction in workforce to reallocate capital to growth areas. : £12.9 million (+27.4%)
: £12.9 million (+27.4%), supported by synthetic biology.